{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-069036","form_type":"8-K","ticker":"NMTC","cik":"0001500198","company_name":"NEUROONE MEDICAL TECHNOLOGIES Corp","filed_at":"2024-08-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.269454+00:00","generated_at":"2026-05-31T09:18:22.174610+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"NeuroOne Q3 product rev up 31% to $826K; net loss narrows to $2.8M; oneRF partnership term sheet signed","bullets":["Product revenue $826K in Q3 FY2024 vs $630K in Q3 FY2023 (+31%); net loss $2.8M vs $3.5M.","Cash and equivalents $1.6M at June 30, 2024; subsequent $2.65M private placement and $3M credit facility in Aug 2024.","Non-binding term sheet with undisclosed global medtech company to distribute OneRF Ablation System.","First OneRF ablation cases completed; CMS granted new ICD-10-PCS code effective Oct 1, 2024.","Operating expenses reduced to $3.1M from $3.8M YoY."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-069036","json":"https://secwatch.observer/filing/0001213900-24-069036.json","markdown":"https://secwatch.observer/filing/0001213900-24-069036.md","text":"https://secwatch.observer/filing/0001213900-24-069036.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1500198/000121390024069036/0001213900-24-069036-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1500198/000121390024069036/ea0211181-8k_neuroone.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T09:18:22.174610+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}